陳國(guó)榮
【摘要】 目的:探究麻甘顆粒聯(lián)合阿奇霉素治療小兒支原體肺炎的臨床療效。方法:選取36例2018年1月-2019年12月在筆者所在醫(yī)院治療的支原體肺炎患兒,均行麻甘顆粒聯(lián)合阿奇霉素治療,觀察本組患兒的治療效果,比較本組患兒治療前后各癥狀評(píng)分、免疫功能的變化情況及不良反應(yīng)的發(fā)生率。結(jié)果:本組患者治療總有效率為94.44%(34/36),治療后各癥狀積分均低于治療前,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);在免疫功能變化方面,治療后患者的RBC-ICR、CD8+等占比低于治療前,PBC-C3bR、CD3+、CD4+占比高于治療前,差異有統(tǒng)計(jì)學(xué)意義(P<0.05);本組患兒中,有1例出現(xiàn)肝腎功能異常,1例出現(xiàn)皮疹,其余患兒未出現(xiàn)明顯的不良反應(yīng),不良反應(yīng)的發(fā)生率為5.56%(2/36)。結(jié)論:臨床上采用麻甘顆粒聯(lián)合阿奇霉素治療支原體肺炎患兒,能夠有效改善患兒的臨床癥狀,增強(qiáng)患兒免疫功能,療效確切,有較高的推廣價(jià)值。
【關(guān)鍵詞】 麻甘顆粒 阿奇霉素 聯(lián)合用藥 小兒支原體肺炎 免疫功能 臨床癥狀
doi:10.14033/j.cnki.cfmr.2020.15.025 文獻(xiàn)標(biāo)識(shí)碼 B 文章編號(hào) 1674-6805(2020)15-00-03
Efficacy of Magan Granules and Azithromycin in the Treatment of Mycoplasma Pneumonia in Children/CHEN Guorong. //Chinese and Foreign Medical Research, 2020, 18(15): -60
[Abstract] Objective: To explore the clinical efficacy of Magan Granules combined with Azithromycin in the treatment of mycoplasmal pneumonia in children. Method: Thirty-six children with mycoplasma pneumonia treated in our hospital from January 2018 to December 2019 were selected, and they were all treated with Magan Granules combined with Azithromycin. The treatment effect of the children in this group was observed and compared, symptom score before and after, changes in immune function, and incidence of adverse reactions. Result: The effective rate of treatment in this group of patients was 94.44% (34/36). The symptom scores after treatment were lower than before treatment, and the difference was significant (P<0.05). In terms of changes in immune function, the proportion of RBC-ICR, CD8+ of this group of patients after treatment etc. were lower than those before treatment, and the proportion of PBC-C3bR, CD3+, and CD4+ was higher than before treatment, the difference was significant (P<0.05). One patient in this group hepatic and renal dysfunction occurred, one case developed a rash, and the other children did not have significant adverse reactions, the incidence of adverse reactions was 5.56% (2/36). Conclusion: The clinical application of Magan Granules combined with Azithromycin in the treatment of children with mycoplasma pneumonia can effectively improve the clinical symptoms of children, enhance the immune function of children, the effect is definite, and it has higher promotion value.
[Key words] Magan Granules Azithromycin Combined use of drug Mycoplasma pneumonia in children Immune function Clinical symptoms
First-authors address: Kunshan Hospital of Integrated Traditional Chinese and Western Medicine, Kunshan 215332, China
本次研究結(jié)果顯示,本組患者治療有效率為94.44%,治療后患兒各癥狀積分均低于治療前,治療后,本組患者的RBC-ICR、CD8+等占比情況低于治療前,PBC-C3bR、CD3+、CD4+占比情況高于治療前,差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。進(jìn)一步提示,麻甘顆粒聯(lián)合阿奇霉素治療支原體肺炎患兒,能夠有效改善患兒的臨床癥狀,還能達(dá)到增強(qiáng)機(jī)體免疫功能的作用,效果顯著。本組患兒不良反應(yīng)的發(fā)生率為5.56%。說(shuō)明,麻甘顆粒與阿奇霉素聯(lián)合使用治療小兒支原體肺炎患兒,并不會(huì)引發(fā)明顯的不良反應(yīng),安全性較高。
綜上所述,臨床上采用麻甘顆粒聯(lián)合阿奇霉素治療支原體肺炎患兒,能夠有效改善患兒的臨床癥狀,增強(qiáng)機(jī)體免疫功能,療效確切,安全性高,建議推廣在更多的臨床上。
參考文獻(xiàn)
[1]劉權(quán)鋒.阿奇霉素治療小兒肺炎支原體肺炎的療效及對(duì)血清相關(guān)炎癥細(xì)胞因子的影響觀察[J].首都食品與醫(yī)藥,2019,26(24):62.
[2]鄒武軍,郭煥利,李曉麗,等.麻甘顆粒聯(lián)合阿奇霉素治療小兒支原體肺炎療效研究[J].陜西中醫(yī),2019,40(11):1582-1585,1589.
[3]梁燕錦,蔡俊欽,黃秀玲.柴桂退熱顆粒聯(lián)合阿奇霉素治療小兒支原體肺炎的療效及免疫功能分析[J].現(xiàn)代診斷與治療,2019,30(16):2741-2743.
[4]陳峰,孫慧明.阿奇霉素聯(lián)合小兒豉翹清熱顆粒治療支原體肺炎效果及降低炎癥細(xì)胞因子水平作用機(jī)制研究[J].山西醫(yī)藥雜志,2019,48(15):1831-1834.
[5]袁麗萍.肅肺解毒湯聯(lián)合阿奇霉素顆粒治療小兒支原體肺炎痰熱閉肺證療效觀察[J].實(shí)用中醫(yī)藥雜志,2019,35(7):830-831.
[6]王延平.雙黃連顆粒聯(lián)合阿奇霉素干混懸劑在小兒支原體肺炎治療中的應(yīng)用效果[J/OL].臨床醫(yī)藥文獻(xiàn)電子雜志,2018,5(94):34-35.
[7]張日安,黃杏雄,陳國(guó)權(quán).阿奇霉素聯(lián)合小兒咳喘靈顆粒治療支原體肺炎患兒的臨床效果與安全性[J].實(shí)用臨床醫(yī)學(xué),2018,19(7):68-69.
[8]羅學(xué)錦.雙黃連顆粒與阿奇霉素干混懸劑聯(lián)合治療小兒支原體肺炎的臨床療效評(píng)價(jià)[J/OL].臨床醫(yī)藥文獻(xiàn)電子雜志,2017,4(33):6489-6490.
[9]任陽(yáng).阿奇霉素聯(lián)合小兒清肺顆粒治療小兒支原體肺炎的臨床療效[J].臨床合理用藥雜志,2018,11(15):70-71.
[10]王斯琦.蟬衣麻甘顆粒治療小兒急性喉支氣管炎寒熱錯(cuò)雜證的臨床研究[D].濟(jì)南:山東中醫(yī)藥大學(xué),2018.
[11]馬璇嵐,何云榮,范永存,等.小兒麻甘顆粒聯(lián)合阿奇霉素治療小兒支原體肺炎療效觀察[J/OL].中藥材,2019(12):2969-2971.
[12]宋貝,楊麗元.小兒肺咳顆粒聯(lián)合阿奇霉素治療兒童支原體肺炎的療效及對(duì)其肺功能、Th1/Th2免疫平衡的影響[J].中國(guó)婦幼保健,2019,34(24):5658-5661.
[13]雷輝,邵榮昌.玉屏風(fēng)顆粒聯(lián)合痰熱清、阿奇霉素治療小兒支原體肺炎臨床觀察[J].陜西中醫(yī),2017,38(5):631-633.
(收稿日期:2020-01-16) (本文編輯:張亮亮)